| Q55044992 | 5-ALA fluorescence and laser Doppler flowmetry for guidance in a stereotactic brain tumor biopsy. |
| Q92872606 | 5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma |
| Q31012120 | 5-Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Surgery of High-Grade Gliomas: A Systematic Review |
| Q37720272 | 5-Aminolevulinic acid fluorescence in high grade glioma surgery: surgical outcome, intraoperative findings, and fluorescence patterns |
| Q96293061 | 5-aminolevulinic acid-guided surgery for recurrent supratentorial paediatric neoplasms |
| Q90031502 | Association Between Supratotal Glioblastoma Resection and Patient Survival: A Systematic Review and Meta-Analysis |
| Q92309050 | Autofluorescence Technology in Glioblastoma Resection: Evolution of New Tool and Approach |
| Q48317583 | Colour contrasting between tissues predicts the resection in 5-aminolevulinic acid-guided surgery of malignant gliomas |
| Q52146989 | Commentary: Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation. |
| Q26799854 | Current trends in the surgical management and treatment of adult glioblastoma |
| Q40235966 | Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells |
| Q38827937 | Extent of Resection in Glioma-A Review of the Cutting Edge. |
| Q57457153 | FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma |
| Q36180449 | Fully Automated Enhanced Tumor Compartmentalization: Man vs. Machine Reloaded. |
| Q37585126 | Handheld confocal laser endomicroscopic imaging utilizing tumor-specific fluorescent labeling to identify experimental glioma cells in vivo |
| Q91809702 | Integration of machine learning and mechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI |
| Q38857027 | Intraoperative Ultrasound Technology in Neuro-Oncology Practice-Current Role and Future Applications |
| Q41523831 | Intraparenchymal brain lesion biopsy guided by a rigid endoscope and navigation system |
| Q102379257 | Macroscopic fluorescence-lifetime imaging of NADH and protoporphyrin IX improves the detection and grading of 5-aminolevulinic acid-stained brain tumors |
| Q48333568 | Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery-review of the literature |
| Q92794895 | Multimodal MRI characteristics of the glioblastoma infiltration beyond contrast enhancement |
| Q30833619 | Neurosurgical oncology: advances in operative technologies and adjuncts |
| Q26778788 | Perspectives in Intraoperative Diagnostics of Human Gliomas |
| Q34515718 | Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey |
| Q37191509 | Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis |
| Q48374101 | Response to journal club: 5-aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging |
| Q35675842 | Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival |
| Q36564218 | The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Mol |
| Q40010516 | The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma |
| Q30873962 | The value of extent of resection of glioblastomas: clinical evidence and current approach |
| Q27028189 | To what extent will 5-aminolevulinic acid change the face of malignant glioma surgery? |
| Q48789215 | Validation of a semi-automatic co-registration of MRI scans in patients with brain tumors during treatment follow-up |
| Q38844368 | Various shades of red-a systematic analysis of qualitative estimation of ALA-derived fluorescence in neurosurgery |
| Q30989894 | What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas? |